Skin chip as well as preparation method and application thereof
By introducing microvascular tissue and pro-inflammatory macrophages M1 into the skin chip, the effects of drugs or cosmetics can be quantified by utilizing changes in cytokine concentrations. This solves the problem of the inability to screen skin application substances in existing technologies, and enables rapid and accurate screening of drugs and cosmetics.
Patent Information
- Application Number
- CN202411100660.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-12
- Publication Date
- 2024-11-15
AI Technical Summary
Existing technologies cannot effectively screen the effects of drugs or cosmetics on skin tissue, nor can they achieve quantitative evaluation of the applied substances.
By introducing microvascular tissue and pro-inflammatory macrophages M1 into skin chips, human skin inflammation is simulated, and the effects of drugs or cosmetics are quantified by changes in cytokine concentration. Skin chips are prepared by combining 3D printing and microfluidic technology.
It enables rapid quantitative evaluation of the effects of drugs or cosmetics, improving screening efficiency and accuracy while reducing costs.
Smart Images

Figure CN118956728A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of organ chips, and in particular to a skin chip and a preparation method and application thereof. Background Art
[0002] After decades of development, microfluidic chip technology and 3D printing technology have shown broad application prospects in different fields. Microfluidic chip technology originated in the 1990s. After 30 years of continuous development, it has achieved remarkable achievements in many fields such as chemical industry, energy, environment and medicine. This technology realizes multiple functions such as micro-analysis, mixing or separation through precise manipulation of tiny liquids. In the medical field, the research on microfluidic chips has not only achieved rapid and economical biochemical analysis, but also brought great impetus to drug screening, medical diagnosis, tissue repair and regeneration.
[0003] Organ chip technology is an important application branch of microfluidics technology. It simulates and replicates the structure and function of multicellular tissues or organs by culturing living cells in micron-level chambers. Compared with traditional 2D cell culture, organ chip technology creates a microfluidic-based culture system that simulates biomechanical forces in the system, such as fluid shear force and tensile stress, by precisely controlling microfluidics. Although 2D cell models have high repeatability, they are less complex than other models. As an example of a more complex platform, scaffold-based 3D cell culture is also considered, which can reproduce the 3D physiological microenvironment in the body for better cell-to-cell interactions, improved function and longer life.
[0004] As a physiological barrier, human skin is responsible for protecting organs and tissues against physical, mechanical, chemical and pathogenic microbial invasions. In recent years, the amount of chemicals and biological agents that the skin is exposed to on a daily basis has continued to increase, such as cosmetics, skin cleansers, environmental pollutants and microbial pathogens. The increase in these factors has triggered various skin reactions, including inflammation, allergies, etc., accompanied by bacterial growth. Therefore, it is crucial to conduct necessary tests on the toxicity of certain substances and the effectiveness of skin drugs.
[0005] Building an in vitro skin chip has become indispensable in scientific experiments, especially in basic biological research and antibacterial dressing research. However, the skin chips currently on the market focus more on how to better restore skin tissue, but cannot test the effect of stimulating skin tissue on cytokine release, thus failing to screen drugs, cosmetics and other applied substances. Summary of the invention
[0006] In order to solve the problem that the prior art cannot screen the applied substances, the present invention provides a method for preparing a skin chip. The preparation method introduces microvascular tissue so that when drugs or other chemical stimulants are applied to the skin chip, the effects are quantified through changes in cytokine concentrations, thereby enabling quantitative evaluation of the effects of the applied substances, thereby solving the problem that the prior art cannot screen the applied substances.
[0007] The technical solution adopted by the present invention to solve its technical problem is:
[0008] A skin chip comprises a chip body and microvascular tissue arranged in the chip body; pro-inflammatory macrophages M1 are inoculated in the chip body; and the microvascular tissue is generated by endothelial cell culture.
[0009] Another object of the present invention is to provide a method for preparing the skin chip as described above, comprising the following steps:
[0010] S1: Generate hydrogel models with pathways by 3D printing using bio-ink containing fibroblasts;
[0011] S2: introducing THP-1 into the pathway of the hydrogel model and inducing it to polarize toward pro-inflammatory macrophage M1 to obtain a first culture chip;
[0012] S3: introducing endothelial cells and vascular growth factors into the passage of the hydrogel model to form microvascular tissue, thereby obtaining a second culture chip;
[0013] S4: Inoculating keratinocytes on the second culture chip for culture to obtain a skin chip.
[0014] Optionally, the fibroblast-containing bio-ink includes a hydrogel matrix, a cross-linking agent and fibroblasts.
[0015] Optionally, the hydrogel matrix is GelMA.
[0016] Optionally, step S2 comprises: after THP-1 is introduced into the passage of the hydrogel model, the THP-1 is treated with cytokines to induce polarization toward pro-inflammatory macrophages M1.
[0017] Optionally, the cytokine is selected from at least one of IFN-γ and LPS.
[0018] Optionally, the endothelial cells are human umbilical vein endothelial cells.
[0019] Another object of the present invention is to provide a method for preparing the skin chip as described above, comprising the following steps:
[0020] S01: preparing a PDMS culture chip with a culture chamber using PDMS;
[0021] S02: perfusing THP-1 into the culture chamber of the PDMS culture chip and inducing it to polarize toward pro-inflammatory macrophage M1;
[0022] S03: introducing endothelial cells into the culture chamber of the PDMS culture chip to form microvascular tissue;
[0023] S04: introducing fibroblasts into the culture chamber of the PDMS culture chip to culture into a dermis layer;
[0024] S05: introducing keratinocytes into the culture chamber of the PDMS culture chip to form skin-like tissue and obtain a skin chip.
[0025] Another object of the present invention is to provide an application of the skin chip as described above in the field of drug screening and cosmetic screening.
[0026] The beneficial effects of the present invention are:
[0027] The skin chip provided by the present invention can simulate human skin inflammation by introducing pro-inflammatory macrophages M1 and microvascular tissue; when drugs or other chemical stimulants are applied to the skin chip, the drug effect can be quantified by the change in cytokine concentration, so that by quickly monitoring the change in cytokine concentration, the effect of the drug or cosmetic can be quantitatively evaluated, thereby realizing the screening of the applied substances. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] The present invention is further described below in conjunction with the accompanying drawings and embodiments.
[0029] Figure 1 is a simplified structural diagram of the hydrogel skin model of the present invention;
[0030] Figure 2 is a simplified structural diagram of a culture device for a hydrogel skin model in the present invention;
[0031] Figure 3 Schematic diagram of the structure of the PDMS skin chip in the present invention.
[0032] In the figure: 11-upper chip; 111-upper liquid inlet; 112-first upper flow channel; 113-upper cell culture chamber; 114-second upper flow channel; 12-porous membrane; 13-lower chip; 131-lower liquid inlet; 132-first lower flow channel; 133-lower cell culture chamber; 134-second lower flow channel; 21-dermis; 22-endothelial layer; 23-epidermis; 31-culture chamber; 32-culture medium input port; 33-waste liquid collection port. DETAILED DESCRIPTION
[0033] The present invention is now further described in detail. The embodiments described below are exemplary and intended to be used to explain the present invention, but cannot be understood as limiting the present invention. All other embodiments obtained by ordinary technicians in this field without creative work based on the embodiments of the present invention belong to the scope of protection of the present invention.
[0034] In the description of the present invention, it should be understood that the terms "first" and "second" are only used to simplify the description, and should not be understood as indicating or implying relative importance, or implicitly indicating the number of the indicated technical features. Thus, the features defined as "first" and "second" may explicitly or implicitly include one or more of the features. In the description of the present invention, the meaning of "plurality" is two or more, unless otherwise clearly and specifically defined.
[0035] In order to make the above-mentioned objects, features and advantages of the present invention more obvious and easy to understand, specific embodiments of the present invention are described in detail below with reference to the accompanying drawings.
[0036] In order to solve the problem that the application cannot be screened in the prior art, the present invention provides a skin chip, which includes a chip body and microvascular tissue arranged in the chip body; and the chip body is inoculated with pro-inflammatory macrophages M1; wherein the microvascular tissue is generated by endothelial cell culture.
[0037] This skin model can provide a skin inflammation environment and candidate anti-inflammatory compounds can be introduced into the microfluidic system for subsequent anti-inflammatory drug screening; the response of the compound to the epidermis and dermis can be monitored, and changes in inflammatory factors can be detected; the effectiveness of the compound can be evaluated based on changes in cytokine production, cell health, and tissue integrity.
[0038] The skin chip provided by the present invention can simulate human skin inflammation by introducing pro-inflammatory macrophages M1 and microvascular tissue; when drugs or other chemical stimulants are applied to the skin chip, the drug effect can be quantified by the change in cytokine concentration, so that by quickly monitoring the change in cytokine concentration, the effect of the drug or cosmetic can be quantitatively evaluated, thereby realizing the screening of the applied substances.
[0039] The skin chip in the present invention may be a hydrogel model; specifically, the skin chip may be prepared according to the following method:
[0040] S1: Generate hydrogel models with pathways by 3D printing using bio-ink containing fibroblasts;
[0041] S2: THP-1 is introduced into the pathway of the hydrogel model and induced to polarize toward pro-inflammatory macrophages M1. For easy distinction, it is recorded as the first culture chip;
[0042] S3: Endothelial cells and vascular growth factors are introduced into the pathway of the hydrogel model to form microvascular tissue, which is recorded as the second culture chip for easy distinction;
[0043] S4: Keratinocytes are inoculated on the second culture chip for culture to obtain a skin chip, i.e., a hydrogel skin model.
[0044] This preparation method uses bio-ink with fibroblasts to form a fibroblast tissue block with a passage through 3D printing, and then introduces THP-1 into the passage of the previously printed model and induces it to polarize toward M1. Endothelial cells are then introduced into the passage to spread evenly and form microvascular tissue; after the first two types of cells are inoculated, the stratum corneum of the skin-like tissue is completed, and then the keratinocytes planted on the hydrogel model are exposed to the air to differentiate and keratinize.
[0045] In the hydrogel skin model, human epidermal keratinocytes were selected for in vitro culture and pretreatment. Keratinocytes were inoculated on the hydrogel for subsequent culture, and this part was exposed to air for a certain period of time to promote the differentiation and keratinization of keratinocytes.
[0046] Specifically, the fibroblast-containing bio-ink of the present invention preferably includes a hydrogel matrix, a cross-linking agent and fibroblasts.
[0047] The hydrogel matrix is composed of a biocompatible polymer that can support cell life and tissue integration to allow the exchange of nutrients and metabolic waste; the preferred hydrogel matrix of the present invention is GelMA.
[0048] To obtain a hydrogel skin model, the present invention selects primary fibroblasts from human skin and uses them after in vitro amplification. Using GelMA as the base material, a hydrogel precursor solution is prepared by adding an appropriate amount of a crosslinking agent (such as a photoinitiator and an absorbent). Then, using precise 3D bioprinting technology, the GelMA hydrogel containing fibroblasts is printed into a shape containing channels according to the designed model parameters.
[0049] Specifically, the preferred crosslinking agent of the present invention is LAP, and further preferably the mass ratio of GelMA, crosslinking agent and fibroblasts in the fibroblast-containing bio-ink is 200:8:5.
[0050] The preferred step S2 of the present invention comprises: after THP-1 is introduced into the passage of the hydrogel model, THP-1 is treated with cytokines to induce polarization to pro-inflammatory macrophage M1; preferably, the cytokines are selected from at least one of IFN-γ, LPS
[0051] Specifically, THP-1 cells were cultured in vitro and pretreated before inoculation to ensure the activity and availability of the cells. After inoculation into the channel of the skin model, THP-1 cells were treated with specific cytokines (such as IFN-γ and LPS) to induce them to differentiate into M1 macrophages. M1 macrophages are a type of pro-inflammatory macrophage that can produce a variety of inflammatory factors to simulate an inflammatory environment.
[0052] In the present invention, the endothelial cells are preferably human umbilical vein endothelial cells.
[0053] In the hydrogel skin model, human umbilical vein endothelial cells (HUVECs) were selected for the vascular endothelial part due to their widespread application in vascular biology research. Endothelial cells were seeded in the hydrogel channel and vascular growth factors (such as VEGF) were added to promote the endothelial cells to form a vascular-like network in the 3D structure. Microfluidics technology was used to design and implement microchannels in the hydrogel to simulate the fluid dynamics environment of blood vessels.
[0054] In summary, the preparation method of the hydrogel skin model provided by the present invention is as follows: first, a suspended THP-1 cell line is introduced into the passage in the hydrogel skin model and dispersed in the passage, and then the cell line is differentiated into pro-inflammatory macrophages M1 by drugs. Subsequently, endothelial cells are cultured in the passage to form a microvascular network to simulate subcutaneous microvascular tissue, and keratinocytes are inoculated on top of the hydrogel skin and exposed to air to promote the differentiation and keratinization of keratinocytes.
[0055] The hydrogel skin model provided by the present invention is used for the bionic manufacture of skin models of the true epidermis and endodermis, and the thickness of the entire chip is less than 2.5 mm; see Figure 1 As shown, the hydrogel skin model is a block structure as a whole, and contains cross-pathways inside, which can inoculate endothelial cells into the intact spread, and can also make the subsequent culture medium flow evenly. The hydrogel skin model includes a dermis 21, a vascular endothelial layer 22 and an epidermis 23. The dermis 21 partly constitutes the basis of the model, mainly composed of fibroblasts, which are evenly distributed in the 3D hydrogel matrix. Fibroblasts are responsible for the production of collagen and other extracellular matrix components, which are essential for maintaining the structural integrity and mechanical strength of the skin model; the vascular endothelial layer 22 partially simulates the vascular system of the skin, and is composed of vascular endothelial cells, which form a microvascular-like structure in the hydrogel. The main function of the vascular endothelial layer is to simulate blood flow and nutrient transport, provide the necessary nutrition and metabolic functions for the skin model, and also serve as a channel for drug transport; the epidermis 23 is located at the outermost layer of the 3D skin model, and is mainly composed of keratinocytes, which can form a multi-layer structure of the epidermis under specific culture conditions.
[0056] The inflammatory simulation of the hydrogel skin model provided by the present invention can be carried out as follows: the inflammatory response of the immune system during skin damage or infection is simulated by the presence of M1 macrophages in the model. This setting can be used to test the effects of anti-inflammatory drugs and observe how they affect the inflammatory factors produced by macrophages.
[0057] See also Figure 2 As shown, when culturing the constructed hydrogel skin model, a microfluidic device prepared with PDMS material in advance can be used to dynamically culture it. Its structure includes four independent culture chambers 31, each of which can accommodate a 3D hydrogel skin model. Each culture chamber 31 is equipped with an independent culture medium input port 32 and a waste liquid collection port 33. This allows each model to independently receive fresh culture medium and collect output liquid for subsequent biochemical analysis and factor detection; at the same time, each culture chamber 31 is equipped with an independent culture medium input port and a waste liquid collection port. This allows each model to independently receive fresh culture medium and collect output liquid for subsequent biochemical analysis and factor detection.
[0058] This design optimizes laminar flow, ensuring even distribution of fluid throughout all culture chambers 31. This is critical to maintaining consistent experimental conditions for each sample.
[0059] During the experiment, the device is placed in an environment that simulates physiological conditions, such as a cell culture incubator.
[0060] During the experiment, the hydrogel model is placed in the culture chamber 31 , and culture medium or test compounds are introduced through the culture medium input port 32 .
[0061] The microfluidic device uses a PDMS substrate, which is biocompatible and optically transparent, facilitating real-time monitoring of samples. The configuration allows independent removal of fluid from each culture chamber 31, preventing cross contamination and enabling parallel processing of samples. The flow path design maintains isolation between samples while allowing collective supply or extraction of fluids through a common bus.
[0062] The skin chip provided by the present invention can be used in the fields of drug screening and cosmetic screening; by measuring changes in inflammatory factors (such as TNF-α, IL-6, etc. levels), the efficacy of drugs can be evaluated.
[0063] The present invention utilizes the air permeability and gas storage characteristics of the PDMS material and utilizes the passive pump principle for sampling; specifically, utilizing the air permeability and gas storage characteristics of the PDMS material, during the degassing process of the vacuum dryer, the air absorbed by the PDMS material is evacuated, and when it contacts the air again, the air will dissolve into the PDMS again through the contact plane between the flow channel and the surface layer. At this time, the detection chip is sealed with tape to isolate most of the places in contact with the air and only the liquid inlet is left as a path for air to enter. When the reaction liquid is passed into the liquid inlet, the air pressure value in the flow channel is reduced because the path for air to enter is blocked. The pressure in the flow channel is reduced, the micropores are in a negative pressure state, and the liquid is pushed in, which realizes negative pressure automatic sampling.
[0064] The skin chip in the present invention may also be a chip prepared by PDMS; specifically, the present invention also provides another method for preparing a skin chip, the preparation method comprising the following steps:
[0065] S01: preparing a PDMS culture chip with a culture chamber using PDMS;
[0066] S02: THP-1 is perfused into the culture chamber of the PDMS culture chip and induced to polarize toward pro-inflammatory macrophage M1;
[0067] S03: introducing endothelial cells into the culture chamber of the PDMS culture chip to form microvascular tissue;
[0068] S04: introducing fibroblasts into the culture chamber of the PDMS culture chip to culture into a dermis layer;
[0069] S05: Keratinocytes are introduced into the culture chamber of the PDMS culture chip to form skin-like tissue, thereby obtaining a skin chip, which is recorded as a PDMS skin chip.
[0070] Preferably, the PDMS skin chip is a glass slide with the bottom as the substrate, and the upper part is the chip body, the chip body is a PDMS flow channel and a culture chamber, including an upper chip and a lower chip, the two layers are separated by a porous membrane, and the bonding method between the chip layers can be molecular bonding, and a plasma cleaning machine is used to clean the surface to be bonded, and then the two surfaces are bonded. An upper culture chamber is provided on the upper chip, and a lower culture chamber is provided at a position corresponding to the upper chamber of the lower chip, and the upper culture chamber and the lower culture chamber are connected through a porous membrane.
[0071] Initially, culture medium was introduced into the upper and lower chambers at the same time for perfusion culture. First, suspended THP-1 cells were perfused onto the porous membrane in the lower chip chamber and induced to polarize toward M1. After polarization, endothelial cells were introduced into the lower chip, and the endothelial cells were perfused and cultured and proliferated in the lower chip chamber to form microvascular tissue; after the first two types of cells were inoculated, the dermis and stratum corneum of the skin-like tissue were perfused and cultured in the upper chamber and formed, and then the upper layer was changed to air to promote the differentiation and keratinization of keratinocytes; specifically, fibroblasts were inoculated just above the porous membrane to simulate the dermis of the skin. After the fibroblasts were attached to the porous membrane and grew normally, keratinocytes were introduced into the upper layer again to simulate the generation of the stratum corneum, and endothelial cells were introduced into the lower layer to simulate the vascular environment. After the four types of cells were co-cultured for 4 days, the upper channel no longer introduced culture medium but introduced air to promote the differentiation and keratinization of keratinocytes, and the lower channel always maintained the introduction of culture medium under the premise of introducing endothelial cells.
[0072] See also Figure 3 As shown, the structure of the PDMS skin chip may include an upper chip 11 and a lower chip 13, and a porous membrane 12 is placed between the upper chip 11 and the lower chip 13. The upper chip 11 is provided with an upper cell culture chamber 113, and the lower chip 13 is provided with a lower cell culture chamber 133. The flow channels in the upper chip 11 and the lower chip 13 adopt a cross-cross design, and the fluid from the liquid inlet can enter the culture chamber evenly from the upper liquid inlet 111 and the lower liquid inlet 131 of the upper chip 11 and the lower chip 13, respectively, and the culture conditions of the upper and lower chambers are exactly the same.
[0073] The upper chip 11 is relatively provided with a first upper channel 112 and a second upper channel 114; the lower chip 13 is relatively provided with a first lower channel 132 and a second lower channel 134; the PDMS skin chip is used to culture in vitro skin-like tissue, and the gas-liquid interface culture can be completed by changing the first upper channel 112 to pass the culture medium / air. On this basis, the culture fluid flows out from the second upper channel 114 to the processing chip for collection, and by monitoring the concentration changes of cytokines before and after the drug is administered, we can evaluate the effect of the drug.
[0074] In order to obtain the skin chip mold, 3D printing method was used to obtain Figure 3For the silicon plate with the same structure as the middle and upper chips and the lower chips, mix the monomer and the curing agent evenly, pour them into the mold, extract the bubbles produced after stirring with a vacuum pump, pour the mixed liquid after removing the bubbles into the silicon plate, place the silicon plate on a heating plate for curing at a temperature of 55°C for 12 hours to form a PDMS solid, peel off the cured PDMS from the silicon plate, and then punch holes at the positions corresponding to the first upper channel 112 and the second upper channel 114, then clamp the porous membrane 12 at the corresponding positions and fit them, place the mold on the heating plate again for 1 hour at a temperature of 55°C, and place a 1 kg weight on it to ensure sealing.
[0075] When using the PDMS skin chip, a certain concentration of THP-1 cells is introduced from the lower liquid inlet 131 into the culture chamber in the PDMS skin chip and stimulated with drugs for 48 hours to generate pro-inflammatory immune cells. After that, endothelial cells are introduced from the lower liquid inlet 131 to grow together on the porous membrane, so that the endothelial cells grow under the porous membrane 12 to form vascular tissue. Two days after the endothelial cells are introduced from the lower liquid inlet 131, a certain concentration of fibroblasts is introduced from the upper liquid inlet 111 to culture into the dermis. After the fibroblasts are spread on the porous membrane 12, a certain concentration of keratinocytes is introduced from the upper liquid inlet 111 two days later, and the two are co-cultured to form skin-like tissue.
[0076] Skin cells are inoculated on the porous membrane 12 for co-culture to form skin-like tissue. The medium introduced into the upper liquid inlet 111 can be changed. The culture medium is introduced initially to promote the rapid growth of skin cells. After 10 days, the medium introduced into the upper liquid inlet 111 can be changed to air to form a gas-liquid interface, thereby promoting the differentiation and keratinization of keratinocytes to increase the functionality and integrity of the generated skin-like tissue.
[0077] The porous membrane 12 in the PDMS skin chip can be made of polycarbonate, preferably with a pore size of 0.4 μm, which is non-toxic to cells, and cells can grow on it, and nutrients can pass through it.
[0078] In some embodiments, the PDMS skin chip can have multiple liquid inlets and outlets, wherein the upper flow channel layer has a liquid outlet corresponding to the liquid inlet of the liquid inlet channel and three liquid outlet channels, and the lower flow channel layer has a liquid outlet corresponding to the liquid inlet of the liquid inlet channel and three liquid outlet channels.
[0079] The liquid inlet and outlet of the PDMS skin chip can be punched with a puncher, and then a steel needle is inserted into the hole. The steel needle can be combined with a hose of corresponding specifications to transport liquid into the flow channel.
[0080] The present invention can simulate intravenous injection of medicine by adding medicine into the culture medium, and the cytokines released by the cells are obtained by testing the culture medium.
[0081] The present invention provides two in vitro co-culture skin models with simple structure and convenient operation; it can provide a complete system for in vitro skin culture and drug effect screening. The system of the present invention can simulate in vitro skin tissue culture and establish an inflammation model, and can verify the effects of different drugs and cosmetics on cell release of cytokines, integrating the process from culture to drug screening.
[0082] This skin model can be used to quickly evaluate the effect of applied substances by detecting skin cytokines. Relying on 3D printing, organ chips and microfluidic technology, we used two different methods to successfully simulate human-like skin tissue, allowing it to be continuously cultured under in vitro conditions. When drugs or other chemical stimulants are applied to the model, the drug effect is quantified by the change in cytokine concentration. The system can quickly monitor the changes in cytokine concentrations, thereby quantitatively evaluating the effects of drugs or cosmetics. By combining 3D printing, organ chips and cytokine detection chip technology, the efficiency of drug and cosmetic screening flow can be ultimately improved. In addition to inflammation detection, this invention can also be widely used in the rapid evaluation of the efficacy of various drugs or cosmetics such as whitening and anti-aging. The application of this integrated method and device will greatly improve the efficiency and accuracy of drug and cosmetic research and development.
[0083] LPS was applied to the pro-inflammatory M1 macrophages induced by THP-1 cells pre-inoculated in an in vitro skin model to induce the production of inflammatory factors to simulate human skin inflammation. The inflammatory factor detection chip was used to detect the changes in inflammatory factors before and after drug application to evaluate the drug effect. This system provides a new and rapid and effective platform for studying new drugs and treatments for skin inflammation.
[0084] The preparation methods of the two skin models of the present invention both use primary fibroblasts to simulate the dermis of human skin, and use stratum corneum cells to simulate the stratum corneum of the skin, and the generations of both cells do not exceed 14 generations; endothelial cells are used to simulate the skin microvascular network; THP-1 cells are used to induce the formation of M1 immune cells to simulate the skin's inflammatory system and the immune cells in the skin.
[0085] Specifically, the present invention uses a precise dose of a drug to stimulate the THP-1 cell line for 48 hours to differentiate it into pro-inflammatory macrophages. The differentiated cells are co-cultured with other cells to produce sufficient inflammatory factors. In addition, the inflammatory factors produced should have typical characteristics so that the pro-inflammatory effect of the drug and the effect of subsequent drug screening can be accurately evaluated. In order to establish a validation model, drugs such as LPS, SDS or ultraviolet rays such as UVA and UVB are selected as external stimulus factors, and the inflammatory factors induced by the detection are TNF-α, IL-6, IL-1β, IL-10, IL-2, etc.
[0086] During the screening of drugs or cosmetics, candidate anti-inflammatory compounds are introduced into the microfluidic system; the response of the compound to the epidermis and dermis is monitored; the effectiveness of the compound is evaluated based on changes in cytokine production, cell health, and tissue integrity. The drug can be administered by simulating intravenous injection, where the PDMS skin model is administered by passing the inlet into the flow channel, and the flow rate is controlled at 6-12μL / min.
[0087] The skin tissue models currently on the market focus more on better restoration of skin tissue, while subsequent inflammatory factor detection still requires a lot of cost. The present invention integrates tissue culture and subsequent inflammatory factor detection into one system through microfluidic chip technology and 3D printing technology, which will greatly save time and cost.
[0088] In terms of detection methods, traditional ELISA technology is greatly interfered by background signals when the test solution is over-diluted, making it difficult to improve the detection sensitivity. The emergence of digital ELISA fills this shortcoming. Digital ELISA is based on microfluidics technology and relies on tiny micropores to make the sample distribution volume smaller, so that fluorescence can accumulate more quickly. The present invention preferably integrates digital ELISA with a skin model into a complete system to provide a more accurate and efficient detection method for the experiment.
[0089] Those skilled in the art can understand that, the upper liquid inlet 111, the first upper flow channel 112, the upper cell culture chamber 113, the second upper flow channel 114, the porous membrane 12, the lower liquid inlet 131, the first lower flow channel 132, the lower cell culture chamber 133, the second lower flow channel 134, the culture medium input port 32, and the waste liquid collection port 33 in the present invention can be made of materials known in the art by known methods.
[0090] The device provided by the present invention integrates two major functions, in vitro skin-like tissue culture and cytokine detection. Therefore, the skin model provided by the present invention can stimulate in vitro skin-like tissue and simultaneously test the effect of the stimulation on cytokine release.
[0091] The skin model provided by the present invention is simple to make, low in cost, and strong in function, and can be used to screen drugs, cosmetics, and the like.
[0092] Based on the above ideal embodiments of the present invention, the relevant staff can make various changes and modifications without departing from the technical concept of the present invention through the above description. The technical scope of the present invention is not limited to the contents of the specification, and its technical scope must be determined according to the scope of the claims.
Claims
1. A skin chip, characterized in that: It comprises a chip body and microvascular tissue arranged in the chip body; pro-inflammatory macrophages M1 are inoculated in the chip body; and the microvascular tissue is generated by endothelial cell culture.
2. A method for preparing a skin chip according to claim 1, characterized in that: The steps include: S1: Generate hydrogel models with pathways by 3D printing using bio-ink containing fibroblasts; S2: introducing THP-1 into the pathway of the hydrogel model and inducing it to polarize toward pro-inflammatory macrophage M1 to obtain a first culture chip; S3: introducing endothelial cells and vascular growth factors into the passage of the hydrogel model to form microvascular tissue, thereby obtaining a second culture chip; S4: Inoculating keratinocytes on the second culture chip for culture to obtain a skin chip.
3. The method for preparing a skin chip according to claim 2, characterized in that: The fibroblast-containing biological ink comprises a hydrogel matrix, a cross-linking agent and fibroblasts.
4. The method for preparing a skin chip according to claim 3, characterized in that: The hydrogel matrix is GelMA.
5. The method for preparing a skin chip according to claim 2, characterized in that: Step S2 comprises: after THP-1 is introduced into the passage of the hydrogel model, the THP-1 is treated with cytokines to induce polarization toward pro-inflammatory macrophage M1.
6. The method for preparing a skin chip according to claim 5, characterized in that: The cytokine is selected from at least one of IFN-γ and LPS.
7. The method for preparing a skin chip according to claim 2, characterized in that: The endothelial cells are human umbilical vein endothelial cells.
8. The method for preparing a skin chip according to claim 1, characterized in that: The steps include: S01: preparing a PDMS culture chip with a culture chamber using PDMS; S02: perfusing THP-1 into the culture chamber of the PDMS culture chip and inducing it to polarize toward pro-inflammatory macrophage M1; S03: introducing endothelial cells into the culture chamber of the PDMS culture chip to form microvascular tissue; S04: introducing fibroblasts into the culture chamber of the PDMS culture chip to culture into a dermis layer; S05: introducing keratinocytes into the culture chamber of the PDMS culture chip to form skin-like tissue, thereby obtaining a skin chip.
9. An application of the skin chip as claimed in claim 1 in the field of drug screening and cosmetic screening.
Citation Information
Cited By
Vascularized skin chip, vascularized skin model and application thereof
CN119823871A
